GlaxoSmithKline's market cap is currently ―. The company's EPS TTM is p1.216; its P/E ratio is 13.48; and it has a dividend yield of 3.63%. GlaxoSmithKline is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is p0.37. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	£ 7.38B	£ 7.83B	£ 6.93B	£ 9.78B	£ 9.53B
Gross Profit	£ 5.14B	£ 5.41B	£ 4.75B	£ 6.09B	£ 5.85B
EBIT	£ 1.84B	£ 1.21B	£ 1.10B	£ 2.81B	£ 890.00M
EBITDA	£ 1.84B	£ 2.17B	£ 1.73B	£ 3.51B	£ 1.26B
Net Income Common Stockholders	£ 1.46B	£ 10.35B	£ 838.00M	£ 1.80B	£ 749.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 7.68B	£ 7.16B	£ 6.53B	£ 13.98B	£ 4.13B
Total Assets	£ 60.15B	£ 60.31B	£ 89.05B	£ 89.69B	£ 79.10B
Total Debt	£ 20.99B	£ 22.11B	£ 22.11B	£ 33.33B	£ 24.17B
Net Debt	£ 13.31B	£ 14.95B	£ 15.58B	£ 19.35B	£ 20.04B
Total Liabilities	£ 50.05B	£ 51.60B	£ 66.41B	£ 67.06B	£ 57.76B
Stockholders Equity	£ 10.60B	£ 9.15B	£ 16.37B	£ 16.18B	£ 15.05B
Cash Flow	-
Free Cash Flow	£ 1.15B	£ 841.00M	£ 1.21B	£ 1.94B	£ 3.13B
Operating Cash Flow	£ 1.91B	£ 1.32B	£ 1.64B	£ 2.54B	£ 3.77B
Investing Cash Flow	£ -540.00M	£ -4.09B	£ -545.00M	£ -3.59B	£ -361.00M
Financing Cash Flow	£ -1.34B	£ -1.33B	£ -4.49B	£ 7.97B	£ -2.77B

Currency in GBP

GlaxoSmithKline Earnings and Revenue History

Income Statement >

GlaxoSmithKline Debt to Assets

Balance Sheet >

GlaxoSmithKline Cash Flow

Cash Flow >

GlaxoSmithKline Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing